Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anni Härkönen
Observed names:
A. Härkönen,
Härkönen, Anni
Institutions:
University of Helsinki,
Helsinki University Hospital,
Institute for Molecular Medicine Finland
Observed institutions:
University of Helsinki,
Tampere University of Applied Sciences,
University of Turku,
Helsinki University Hospital,
Institute for Molecular Medicine Finland
OpenAlex ID:
A5114879954
Length of Ischemic Time Is Critical for Accurate Determination of Homologous Recombination Capacity by Immunofluorescence Staining in Ovarian Cancer Formalin-Fixed Paraffin-Embedded Samples
2026
·
Ezgi Karagöz
, Sanna Pikkusaari
, et al.
·
Archives of Pathology & Laboratory Medicine
·
1
Real-world data from the oncosys-OVA clinical trial (NCT06117384) - experiences on genomic and functional HRD testing and molecular determinants of progression during PARP inhibitor treatment
2026
·
Anni Härkönen
, Matilda Salko
, et al.
·
International Journal of Gynecological Cancer
1200P Improved clinical HRD testing practices in ovarian cancer based on real-world data from the Oncosys-OVA clinical trial
2025
·
M. Salko
, A. Härkönen
, et al.
·
Annals of Oncology
”Jokuhan täyttää sen tyhjiön” : Asiantuntijoiden kokemuksia julkisena asiantuntijana toimimisesta korona-aikana
2025
·
Härkönen, Anni
·
Tampere University Institutional Repository (Tampere University)
Show more works
View as search
Works count:
7
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type